Annual CFO
$5.82 B
-$8.50 B-59.39%
31 December 2023
Summary:
BioNTech SE annual cash flow from operations is currently $5.82 billion, with the most recent change of -$8.50 billion (-59.39%) on 31 December 2023. During the last 3 years, it has risen by +$5.83 billion (+37817.94%). BNTX annual CFO is now -59.39% below its all-time high of $14.32 billion, reached on 31 December 2022.BNTX Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$672.46 M
-$2.43 B-138.32%
01 September 2024
Summary:
BioNTech SE quarterly cash flow from operations is currently -$672.46 million, with the most recent change of -$2.43 billion (-138.32%) on 01 September 2024. Over the past year, it has dropped by -$1.55 billion (-176.67%). BNTX quarterly CFO is now -114.09% below its all-time high of $4.77 billion, reached on 30 June 2023.BNTX Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
$1.63 B
-$1.55 B-48.72%
01 September 2024
Summary:
BioNTech SE TTM cash flow from operations is currently $1.63 billion, with the most recent change of -$1.55 billion (-48.72%) on 01 September 2024. Over the past year, it has dropped by -$4.77 billion (-74.51%). BNTX TTM CFO is now -88.61% below its all-time high of $14.32 billion, reached on 31 December 2022.BNTX TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BNTX Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -59.4% | -176.7% | -74.5% |
| 3 y3 years | +10000.0% | -137.8% | +3.5% |
| 5 y5 years | +8464.4% | -1151.2% | +1187.4% |
BNTX Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -59.4% | >+9999.0% | -114.1% | +7.6% | -88.6% | +55.0% |
| 5 y | 5 years | -59.4% | +2716.8% | -114.1% | +7.6% | -88.6% | +475.7% |
| alltime | all time | -59.4% | +2716.8% | -114.1% | +7.6% | -88.6% | +475.7% |
BioNTech SE Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$672.46 M(-138.3%) | $1.63 B(-48.7%) |
| June 2024 | - | $1.76 B(-609.2%) | $3.18 B(-48.7%) |
| Mar 2024 | - | -$344.65 M(-138.6%) | $6.20 B(+6.6%) |
| Dec 2023 | $5.82 B(-59.4%) | $893.27 M(+1.8%) | $5.82 B(-9.1%) |
| Sept 2023 | - | $877.10 M(-81.6%) | $6.40 B(-35.2%) |
| June 2023 | - | $4.77 B(-755.9%) | $9.87 B(+9.2%) |
| Mar 2023 | - | -$727.55 M(-149.3%) | $9.05 B(-36.8%) |
| Dec 2022 | $14.32 B(+1260.2%) | $1.48 B(-66.1%) | $14.32 B(+13.5%) |
| Sept 2022 | - | $4.35 B(+10.4%) | $12.61 B(+25.6%) |
| June 2022 | - | $3.94 B(-13.2%) | $10.04 B(+68.1%) |
| Mar 2022 | - | $4.54 B(-2062.7%) | $5.97 B(+467.4%) |
| Dec 2021 | $1.05 B | -$231.55 M(-113.0%) | $1.05 B(-33.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | $1.78 B(-1572.2%) | $1.58 B(-463.0%) |
| June 2021 | - | -$120.93 M(-67.8%) | -$434.16 M(+31.5%) |
| Mar 2021 | - | -$375.12 M(-228.6%) | -$330.18 M(+2041.6%) |
| Dec 2020 | -$15.42 M(-93.1%) | $291.78 M(-226.9%) | -$15.42 M(-95.9%) |
| Sept 2020 | - | -$229.89 M(+1256.4%) | -$379.41 M(+86.7%) |
| June 2020 | - | -$16.95 M(-71.9%) | -$203.27 M(-17.7%) |
| Mar 2020 | - | -$60.36 M(-16.4%) | -$247.12 M(+11.2%) |
| Dec 2019 | -$222.22 M(+219.6%) | -$72.21 M(+34.4%) | -$222.22 M(+48.1%) |
| Sept 2019 | - | -$53.75 M(-11.6%) | -$150.01 M(+55.8%) |
| June 2019 | - | -$60.80 M(+71.5%) | -$96.26 M(+171.5%) |
| Mar 2019 | - | -$35.46 M | -$35.46 M |
| Dec 2018 | -$69.52 M(+16.8%) | - | - |
| Dec 2017 | -$59.53 M | - | - |
FAQ
- What is BioNTech SE annual cash flow from operations?
- What is the all time high annual CFO for BioNTech SE?
- What is BioNTech SE annual CFO year-on-year change?
- What is BioNTech SE quarterly cash flow from operations?
- What is the all time high quarterly CFO for BioNTech SE?
- What is BioNTech SE quarterly CFO year-on-year change?
- What is BioNTech SE TTM cash flow from operations?
- What is the all time high TTM CFO for BioNTech SE?
- What is BioNTech SE TTM CFO year-on-year change?
What is BioNTech SE annual cash flow from operations?
The current annual CFO of BNTX is $5.82 B
What is the all time high annual CFO for BioNTech SE?
BioNTech SE all-time high annual cash flow from operations is $14.32 B
What is BioNTech SE annual CFO year-on-year change?
Over the past year, BNTX annual cash flow from operations has changed by -$8.50 B (-59.39%)
What is BioNTech SE quarterly cash flow from operations?
The current quarterly CFO of BNTX is -$672.46 M
What is the all time high quarterly CFO for BioNTech SE?
BioNTech SE all-time high quarterly cash flow from operations is $4.77 B
What is BioNTech SE quarterly CFO year-on-year change?
Over the past year, BNTX quarterly cash flow from operations has changed by -$1.55 B (-176.67%)
What is BioNTech SE TTM cash flow from operations?
The current TTM CFO of BNTX is $1.63 B
What is the all time high TTM CFO for BioNTech SE?
BioNTech SE all-time high TTM cash flow from operations is $14.32 B
What is BioNTech SE TTM CFO year-on-year change?
Over the past year, BNTX TTM cash flow from operations has changed by -$4.77 B (-74.51%)